Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

(TSX:SVA)

0.1400 UNCHANGED
Streaming Delayed Price Updated: 3:56 PM EST, Feb 23, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 21,225
Open 0.1400
Bid (Size) 0.1400 (235)
Ask (Size) 0.1450 (435)
Prev. Close 0.1400
Today's Range 0.1400 - 0.1400
52wk Range 0.1200 - 0.2300
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
ORBIMED Advisors Trims $125 Million Terns Stake After a Breakout Year, According to SEC Filing ↗
Terns Pharmaceuticals has delivered a significant rally over the past year, lifting expectations around its clinical pipeline. The latest filing shifts attention to upcoming data and the company’s... 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
SINOVAC Announces Nasdaq Hearings Panel Grants Continued Listing
From Sinovac Biotech Ltd.
Via Business Wire

Performance

YTD
+12.0%
+12.0%
1 Month
-15.2%
-15.2%
3 Month
+12.0%
+12.0%
6 Month
-22.2%
-22.2%
1 Year
-30.0%
-30.0%

More News

Read More
News headline image
SINOVAC Provides Update on Antigua High Court Order and Auditor Engagement
From Sinovac Biotech Ltd.
Via Business Wire
News headline image
Sinovac Receives Nasdaq Notification Regarding Late Filing of 2025 Half-Year Report
From Sinovac Biotech Ltd.
Via Business Wire
News headline image
Sinovac: Antigua Court Makes Interim Order Giving Board Control of the Company until the Trial of the Disputed 2025 Shareholder Meeting
From Sinovac Biotech Ltd.
Via Business Wire
News headline image
From Insulin Injections to Functional Cures: Regenerative Medicine Reshapes Diabetes
From USA News Group
Via GlobeNewswire
News headline image
Newly Elected Directors of Sinovac Hold the First Board Meeting
From Sinovac Biotech Ltd.
Via Business Wire
News headline image
Sinovac Shareholders Vote to Remove Current Directors and Elect SAIF Partners Nominees to Board at Special Meeting
From SAIF Partners IV L.P.
Via Business Wire
News headline image
Appeal Decision By Eastern Caribbean Supreme Court Supports Right of Prime Success and Vivo Capital to Participate in Critical Sinovac Biotech Shareholder Vote
From Vivo Capital
Via Business Wire
News headline image
CORRECTING and REPLACING SAIF Partners: Now is Your Last Chance to Vote for Board Change at Sinovac
From SAIF Partners IV L.P.
Via Business Wire
News headline image
United States District Court of Massachusetts Bars Activist 1Globe Capital and Jiaqiang Li From Making Further Materially Misleading Statements Regarding Sinovac
From Vivo Capital
Via Business Wire
News headline image
SAIF Partners Sends Letter to Sinovac Shareholders
From SAIF Partners IV L.P.
Via Business Wire
News headline image
SAIF Partners Sends Open Letter to Sinovac Shareholders Outlining Current Board’s Failure to Act in the Interests of Shareholders
From SAIF Partners IV L.P.,
Via Business Wire
News headline image
Sinovac Clears Legal Hurdle In Control Battle, Moves Forward With $55 Dividend ↗
Via Stocktwits
News headline image
Prime Success Issues Statement on New York State Court Decision Confirming Our Rights as Sinovac Shareholders – Including Right to Vote at Upcoming Special Meeting
From Prime Success L.P.
Via Business Wire
News headline image
SINOVAC Announces New Board Member
From Sinovac Biotech Ltd.
Via Business Wire
News headline image
Prime Success Sets the Record Straight Regarding Continued False and Misleading Statements from Sinovac Biotech’s Current Board
From Prime Success L.P.
Via Business Wire
News headline image
SAIF Partners Files Definitive Proxy Materials in Connection with Sinovac Biotech 2025 Special Meeting of Shareholders; Nominates Ten Highly Qualified Director Candidates to the Board
From SAIF Partners IV L.P.
Via Business Wire
News headline image
SINOVAC Board of Directors Alerts Shareholders to Advantech/Prime Success’ New Lawsuit, Which Threatens to Prevent Payment of US$55.00 Special Dividend to All Valid Shareholders
From SINOVAC Biotech Ltd.
Via Business Wire
News headline image
Prime Success Responds to Sinovac Biotech’s False and Misleading Claims
From Prime Success L.P.
Via Business Wire
News headline image
SINOVAC’s Board of Directors Issues a Letter to Shareholders Outlining Clear Pathway to Restore Fairness and Deliver Value to All Shareholders
From Sinovac Biotech Ltd.
Via Business Wire
News headline image
Vivo Capital Issues Letter to Sinovac Biotech Shareholders Addressing the Company’s False and Misleading Claims
From Vivo Capital
Via Business Wire
News headline image
Prime Success Sends Letter to Sinovac Biotech Shareholders
From Prime Success L.P.
Via Business Wire
News headline image
SINOVAC Receives Nasdaq Notification Regarding Late Filing of 2024 Annual Report
From Sinovac Biotech Ltd.
Via Business Wire
News headline image
SINOVAC Announces Record and Distribution Dates for Special Cash Dividend
From Sinovac Biotech Ltd.
Via Business Wire

Frequently Asked Questions

Is SVA publicly traded?
Yes, SVA is publicly traded.
What exchange does SVA trade on?
SVA trades on the Toronto Stock Exchange
What is the ticker symbol for SVA?
The ticker symbol for SVA is SVA on the Toronto Stock Exchange
What is the current price of SVA?
The current price of SVA is 0.1400
When was SVA last traded?
The last trade of SVA was at 02/23/26 03:56 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.